A carregar...

Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models

Despite numerous therapeutic advances in the past decade, breast cancer is expected to cause over 42,000 deaths in the United States in 2019. Breast cancer had been considered an immunologically silent tumor; however recent findings suggest that immune cells play important roles in tumor growth even...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Breast Cancer
Main Authors: Leal, Ana S., Zydeck, Kayla, Carapellucci, Sarah, Reich, Lyndsey A., Zhang, Di, Moerland, Jessica A., Sporn, Michael B., Liby, Karen T.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825145/
https://ncbi.nlm.nih.gov/pubmed/31700995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0135-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!